Lansdale, PA, United States of America

Jian Wang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.7

ph-index = 1


Location History:

  • Neshanic Station, NJ (US) (2012)
  • Lansdale, PA (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jian Wang in Biotechnology

Introduction

Jian Wang is an accomplished inventor based in Lansdale, PA. With a remarkable contribution to the field of biotechnology, he holds two patents that reflect his innovative spirit and dedication to advancing scientific knowledge. His work primarily focuses on the innovative use of eukaryotic cell display systems and the synthesis of novel crystalline forms, showcasing his expertise in both genetic engineering and pharmaceutical development.

Latest Patents

Wang's first patent, titled "Eukaryotic Cell Display Systems," introduces groundbreaking expression vectors and helper display vectors designed for the display of polypeptides on the outer surface of eukaryotic host cells. This invention allows for the efficient and versatile combination of vector sets, enabling the display of diverse libraries of polypeptides on yeast and mammalian cells. It represents a significant leap in biotechnology by facilitating soluble expression while maintaining the integrity of display vectors.

The second patent, "Crystalline Forms of MC4R Agonist and Process for Synthesis," pertains to a novel process for producing specific crystalline salts, hydrates, solvates, and polymorphic forms of a compound used in pharmacology. This invention not only enhances the understanding of the MC4R agonist but also has implications for developing new therapeutic options.

Career Highlights

Jian Wang is an integral part of Merck Sharp & Dohme Corporation, a leading company dedicated to pharmaceuticals and biotechnology. His work at Merck underscores his commitment to innovation within the industry, contributing to projects that aim to improve healthcare solutions through cutting-edge research and development.

Collaborations

Wang collaborates with talented individuals such as Kevin Caili Wang and Peter Peizhi Luo, contributing to an environment of collective innovation. This collaboration enhances the development of new technologies and methodologies within their respective projects, ultimately leading to advancements in biomedical research.

Conclusion

In summation, Jian Wang's inventive contributions to biotechnology through his patents are a testament to his innovative mindset and research capabilities. His work, particularly within Merck Sharp & Dohme Corporation, positions him as a significant player in the ever-evolving landscape of scientific advancement. With a focus on developing essential tools and compounds, he continues to push the boundaries of what is possible in the realm of genetics and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…